When the COVID-19 pandemic began in March 2020, the world did not have available treatment or vaccines for the new virus and respiratory disease. To u...
On December 9, 2021, the U.S. Food and Drug Administration (FDA) released draft guidance entitled “Considerations for the Use of Real-World Data and...
Season 1 - Episode 19 - Accelerating Antibiotic Discovery Using AI
Discusses the use of artificial intelligence (AI) to accelerate antibiotic discove...
"What CITI Program is Reading" is our weekly blog series which highlights news articles curated by our staff and relevant to research, higher educatio...
"What CITI Program is Reading" is our biweekly blog series which highlights news articles curated by our staff and relevant to research, higher educat...
Season 3 - Episode 14 - When Research Ends: Institutional Responsibility, Participant Protection, and Research Integrity
In this episode, we examine ...
Introduction
The National Institutes of Health (NIH) Office of Science Policy (OSP) has unveiled a Notice of Special Interest (NOSI) for Administrati...
This module goes beyond the basic overview and reviews the organizational duties of controllers and processors under the GDPR, including obligations t...
The use of technologies, such as mobile apps, wearable devices, artificial or augmented intelligence (AI), machine learning, and nanotechnology, will ...
